Cure My Disease

Don't miss your cure!

 Log in / Sign up

Electric leg device tested for swelling relief

NCT ID NCT04704557

Symptom relief Sponsor: Firstkind Ltd Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at a device called geko™ that uses mild electrical pulses to stimulate a nerve in the leg, aiming to reduce swelling (edema). Researchers tracked safety and patient outcomes in 35 adults using the device as part of their standard care for up to 12 months. The goal was to see how safe and effective the device is in real-world use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
geko™ Neuromuscular Electro Stimulator (NMES) device
What this could lead to
If successful, this could confirm the geko™ device is a safe and effective option for managing leg swelling in routine care.
What could go wrong
This was a small, terminated registry study (35 participants) with no control group, so results may be limited and not generalizable. The device may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

35 people

The number who actually took part.

Started

Jun 2021

Finished

Nov 2021

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants who have been identified to receive gekoTM therapy as part of their standard care for oedema reduction.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years and able to provide written informed consent. * Intact healthy skin at the site of gekoTM device application. * Subjects receiving gekoTM therapy as part of their standard care for oedema reduction. Exclusion Criteria: * Pregnancy or breast feeding. * Use of any concurrent neuro-modulation device. * Trauma to the lower limbs that would prevent geko™ from stimulating the common peroneal nerve. * No involuntary movement of the lower leg/foot at the maximum tolerable device setting.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Edema leg are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Edema leg

Contacts and locations

Locations

  • Cliniques Universitaires Saint-Luc

    Brussels, Brussels Capital, 1200, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.